Mentions
Extended reach
Total likes
Video views
AI synopsis
The groups of discussions collectively show a strong belief in the transformative potential of psilocybin for smoking cessation, using enthusiastic language like 'most effective' and references to high success rates (80%), along with questions about dosage effects, which reveal active engagement and curiosity about the research. Technical references and comparisons to existing treatments highlight the perceived high impact of these findings.
Most discussions highlight the promising results of the study, emphasizing high quit rates and comparing them favorably to traditional treatments.
The posts demonstrate a high level of curiosity about psilocybin's potential, with mentions of future research and different applications, indicating strong engagement with the topic.
Several posts provide detailed summaries, comparisons, and questions about the methodology, showing deep involvement in understanding the implications.
The discussions suggest that the findings could significantly influence future approaches to addiction treatment, potentially reshaping perceptions of psychedelics in medicine.
"the most effective smoking cessation medications typically demonstrate < 31% abstinence at 12 months post-treatment, whereas [magic mushrooms
As far as I know, this is the only study that comments on whether a second dose of psilocybin increases response rates for any condition. “All participants who quit smoking did so after their initial moderate-dose session.” Anyone know of any other data? https://t.co/pi6ciqb5B6
The highest rate of treatment success for tobacco addiction is….. shrooms!
Enter psilocybin, Nayak describes the 2014 smoking cessation trial 15 participants 80% quit smoking (6 months) 67% still smoke-free at 12 months But, open-label trial, so take it with a grain of salt https://t.co/edpkpqbqJG
pubmed.ncbi.nlm.nih.gov/41008340/ adicciones y psicodélicos pubmed.ncbi.nlm.nih.gov/25213996/ tabaco y psilocibina pubmed.ncbi.nlm.nih.gov/35711024/ psilocibina y desórdenes asociados a trauma
More notes on this study: https://t.co/QCGqXSfLxk Original study: https://t.co/edpkpqbqJG
Explore the potential therapeutic effects of psilocybin, highlighting its ability to reduce depression and anxiety in patients. This video discusses key studies showcasing the efficacy of psilocybin combined with…
Discover psychedelics and their therapeutic potential. This video explores how psychedelics, like psilocybin, significantly alter brain function, assisting in the treatment of mental health disorders such as depression…
pubmed.ncbi.nlm.nih.gov/41008340/ adicciones y psicodélicos pubmed.ncbi.nlm.nih.gov/25213996/ tabaco y psilocibina pubmed.ncbi.nlm.nih.gov/35711024/ psilocibina y desórdenes asociados a trauma
@PortSzymon @MMalolepszy93 Pierdolenie, SYSTEM ci wmówił, żebyś nie jadł bo poszerzają świadomość. Poza tym te grzyby skutecznie wyprowadzają z nałogów: Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction https://t.co/SU9CM7BZQB
As far as I know, this is the only study that comments on whether a second dose of psilocybin increases response rates for any condition. “All participants who quit smoking did so after their initial moderate-dose session.” Anyone know of any other data? https://t.co/pi6ciqb5B6
@tkaiser_science Here is a small pilot study testing psilocybin + CBT for nicotine use disorder: https://t.co/p6tuqKExFm A larger study from the same group @JHPsychedelics has been concluded recently. Looking forward to see the results.
The highest rate of treatment success for tobacco addiction is….. shrooms!
Enter psilocybin, Nayak describes the 2014 smoking cessation trial 15 participants 80% quit smoking (6 months) 67% still smoke-free at 12 months But, open-label trial, so take it with a grain of salt https://t.co/edpkpqbqJG
RT @raphaels7: "the most effective smoking cessation medications typically demonstrate < 31% abstinence at 12 months post-treatment, wherea…
RT @raphaels7: "the most effective smoking cessation medications typically demonstrate < 31% abstinence at 12 months post-treatment, wherea…
RT @raphaels7: "the most effective smoking cessation medications typically demonstrate < 31% abstinence at 12 months post-treatment, wherea…
"the most effective smoking cessation medications typically demonstrate < 31% abstinence at 12 months post-treatment, whereas [magic mushrooms
More notes on this study: https://t.co/QCGqXSfLxk Original study: https://t.co/edpkpqbqJG
@EU_Health Did you know that LSD is very promising for help with smoking session. Here's some research you need to read up to improve your anti smoking laws and actually help people quit: https://t.co/ZpmltkZXsC https://t.co/zNiiIpXoJS #HarmReduction @PhilipMorris_NL
RT @Sansero_Life: Pilot Study of the 5-HT2AR Agonist #Psilocybin in the Treatment of Tobacco Addiction https://t.co/vMLIbDLB9H #psilocybin…
Pilot Study of the 5-HT2AR Agonist #Psilocybin in the Treatment of Tobacco Addiction https://t.co/vMLIbDLB9H #psilocybinresearch #tobacco
RS
BB
MM
B
W
MW
GJ
DD
ＮＳ
CM
M
SS